☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search
Search here
Search here
Subscribe Now
divest
Lonza to Divest Specialty Ingredients Business to Bain Capital and Cinven for $4.7B
February 10, 2021
Takeda to Divest TachoSil to Corza Health for ~$416M
September 16, 2020
Takeda to Divest its Consumer Health Unit to Blackstone for $2.3B in Japan
August 24, 2020
Takeda to Divest OTC and Select Non-core Assets to Celltrion for ~ $278M
June 12, 2020
Takeda to Divest Select OTC and Non-Core Assets in Europe to Orifarm for $670M
April 24, 2020
Takeda to Divest a Portfolio of Select OTC and Non-Core Assets to Hypera Pharma in Latin America for $825M
March 2, 2020
Load more...
Back to Home
Modal title
×
Modal body text goes here.